Malignant Melanoma Drugs Market Size And Share

  • Report Code : TIPRE00021899
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

악성 흑색종 치료제 시장 점유율 분석 및 기회 [2025-2031]

Buy Now

Malignant Melanoma Drugs Market Report Analysis

Malignant Melanoma Drugs Market

  • CAGR (2025 - 2031)
    9.2%
  • Market Size 2024
    US$ XX million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • AstraZeneca
  • Amgen, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Bristol-Myers Squibb Company
  • Novartis AG
  • Merck and Co., Inc.
  • Daiichi Sankyo Company, Limited
  • AB Sciences.
  • Genentech, Inc.

Regional Overview

  • 북미
  • 유럽
  • 아시아 태평양
  • 남미 및 중앙아메리카
  • 중동 및 아프리카

Market Segmentation

By 약물
  • 옵디보
  • 예르보이
  • 메키니스트+타핀라
  • 키트루다
  • 코텔릭
  • 젤보라프
  • 임리직
  • 제네릭
By 질병 유형
  • 악성 흑자 흑색종
  • 말단 흑자 흑색종
  • 결절성 흑색종
  • 표재 확산 흑색종
By 지리
  • 북미
  • 유럽
  • 아시아 태평양
  • 남미 및 중미
  • 중동 및 아프리카